The FDA-approved Moderna mRNA flu vaccine offers modest improvements over standard vaccines for ages 50-64, with mild side effects, and experts advise timely vaccination over waiting.
The FDA-approved Moderna mRNA flu vaccine offers modest improvements over standard vaccines for ages 50-64, with mild side effects, and experts advise timely vaccination over waiting.
